Chardan’s 9th Annual Genetic Medicines Conference – October 21, 2025
Company management will participate in an RNA Editing panel at 1:00 p.m. ET and will conduct 1x1 investor meetings in conjunction with the conference.
H.C. Wainwright Liver Disease Virtual Conference – October 21-22, 2025
Presentation available on demand beginning October 21 at 7:00 am ET and virtual 1x1s on October 22
ProQR is participating in the H.C. Wainwright Genetic Medicines Virtual Conference – October 14-15, 2025
Presentation available on demand beginning October 14 at 7:00 am ET and virtual 1x1s on October 15
ProQR's Annual General Meeting (AGM) of Shareholders will take place on Tuesday, June 3, 2025 at 1530 CEST at the offices of Allen Overy Shearman Sterling LLP, in Amsterdam, the Netherlands.
ProQR will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am until approximately 12:30 pm EST, including an Analyst Q&A session with members of the ProQR Management Team.
ProQR will host an investor webcast on May 9, 2024 at 8:00 am EDT with members of the ProQR Management Team to highlight the data being presented in the ASGCT 2024 poster session and will also conduct an analyst Q&A session.